Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Quanbin Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-9491-2647; OpenAlex author ID A5101500924, A5128450676. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxa… Co-author DOI 10.1016/j.biopha.2026.119213↗
  2. A glycogen derived from sea urchin-Strongylocentyotus internedius shifts macrophages to the M1 phenotype and enhances the anti-pancreatic cancer activity of ge… Last author DOI 10.3389/fphar.2025.1600349↗
  3. Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin. Co-author DOI 10.1016/j.biopha.2024.116360↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ning Wu · 3 shared papers, 2024–2026 · strength 0.84
  2. Zhenzhen Deng · 2 shared papers, 2024–2025 · strength 0.51
  3. Zhenzhen Deng · 1 shared paper, 2026 · strength 0.33
  4. Jing Wang · 1 shared paper, 2025 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.